Smart Cancer Drugs, Psychedelics, and TB Targets
Kilder
- Statnews: AACR 2026: More strong data for Revolution Medicines’ KRAS drug - statnews.com
- statnews.com: AACR 2026: More strong data for Revolution Medicines’ KRAS drug - statnews.com
- oncodaily.com: Zoldonrasib Shows Early Strength in Previously Treated KRAS G12D NSCLC - Oncodaily
- finance.yahoo.com: Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting - Yahoo Finance
- Nature: Magnetic muon measurements and gene-therapy advances win US$3 million Breakthrough prizes - Nature
- Fiercebiotech: AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs - Fierce Biotech
- fiercebiotech.com: AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs - Fierce Biotech
- Statnews: How Trump is pushing psychedelics reform through the health agencies - statnews.com
- statnews.com: How Trump is pushing psychedelics reform through the health agencies - statnews.com
- Nature: Mycobacterium tuberculosis long-chain fatty acid resistome reveals universal stress protein TB15.3 as essential for infection - Nature
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.